MNK 8-K 2.20.14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 20, 2014
Mallinckrodt public limited company
(Exact name of registrant as specified in its charter)
|
| | |
Ireland | 001-35803 | 98-1088325 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Damastown, Mulhuddart
Dublin 15, Ireland
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: +353 1 880-8180
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
| |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 Regulation FD Disclosure.
In connection with Mallinckrodt plc's ("the Company") proposed acquisition of Cadence Pharmaceuticals, Inc. ("Cadence"), the Company has commenced the process of syndicating the commitments under the credit facilities provided pursuant to a debt commitment letter dated February 10, 2014, which it has filed as Exhibit (b)(1) to the Tender Offer Statement on Schedule TO filed with the Securities and Exchange Commission on February 19, 2014. As of February 11, 2014, the date the Company announced its proposed acquisition of Cadence, Mallinckrodt plc had cash on hand of approximately $350 million.
The information contained in Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as otherwise expressly set forth by specific reference in such a filing.
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| | | | |
| | | | MALLINCKRODT PUBLIC LIMITED COMPANY |
| | | | (registrant) |
| | | | |
Date: | February 20, 2014 | | By: | /s/ Peter G. Edwards |
| | | Name: | Peter G. Edwards |
| | | Title: | Senior Vice President and General Counsel |